Insulin is a particularly egregious example of what has happened with drug pricing in our country.
Editor's note · Context
Kim Schrier discusses the issue of drug pricing in the U.S., focusing on insulin.
Share
More from Kim Schrier
This bipartisan bill would codify and authorize the RNGR program with its own budget line item and funding.
Whatever we can do to expand affordable care, improve healthcare, strengthen the doctor-patient relationship, and bring down costs is a win for our constituents. That is why I am excited to sponsor this bill, the Medicaid Primary Care…
I am here today to speak about the epidemic of gun violence that continues to plague our country. In fact, gun violence is now the leading cause of death for children. As a pediatrician, I understand that we have to look at this as a…
We have all talked about thinning forests, making them more resilient. We talked about the risk of catastrophic wildfire. We passed a big infrastructure bill a couple years ago, and part of that was not just protecting roads and bridges…





